Michael Chen to Carcinoma, Squamous Cell
This is a "connection" page, showing publications Michael Chen has written about Carcinoma, Squamous Cell.
Connection Strength
0.451
-
Tu HF, Chen MY, Lai JC, Chen YL, Wong YW, Yang CC, Chen HY, Hsia SM, Shih YH, Shieh TM. Arecoline-regulated ataxia telangiectasia mutated expression level in oral cancer progression. Head Neck. 2019 08; 41(8):2525-2537.
Score: 0.145
-
Chiu CF, Bai LY, Kapuriya N, Peng SY, Wu CY, Sargeant AM, Chen MY, Weng JR. Antitumor effects of BI-D1870 on human oral squamous cell carcinoma. Cancer Chemother Pharmacol. 2014 Feb; 73(2):237-47.
Score: 0.101
-
Chang CM, Chang PY, Tu MG, Lu CC, Kuo SC, Amagaya S, Lee CY, Jao HY, Chen MY, Yang JS. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2. Oncol Rep. 2012 Nov; 28(5):1799-807.
Score: 0.092
-
Shih YH, Chang KW, Chen MY, Yu CC, Lin DJ, Hsia SM, Huang HL, Shieh TM. Lysyl oxidase and enhancement of cell proliferation and angiogenesis in oral squamous cell carcinoma. Head Neck. 2013 Feb; 35(2):250-6.
Score: 0.089
-
Tsai SC, Lu CC, Lee CY, Lin YC, Chung JG, Kuo SC, Amagaya S, Chen FN, Chen MY, Chan SF, Yang JS. AKT serine/threonine protein kinase modulates bufalin-triggered intrinsic pathway of apoptosis in CAL 27 human oral cancer cells. Int J Oncol. 2012 Nov; 41(5):1683-92.
Score: 0.023